Chinese media reported that China's independently developed nuclear magnetic resonance instrument has been successfully developed and has begun mass production, breaking the monopoly of this cutting -edge medical equipment technology abroad.
According to China CCTV News on Saturday (July 22), the latest generation of domestic nuclear magnetic resonance instruments developed by Shenzhen Advanced Technology Research Institute of the Chinese Academy of Sciences has fully met the quality requirements of the image of the hospital, which can be quickly obtained.The body image of the human body not only has a higher resolution, but also greatly speeds up imaging.
Zhang Hui, deputy director of the medical imaging department of Peking University Shenzhen Hospital, introduced that the image quality of the new instrument is not inferior to the international advanced nuclear magnetic resonance instrument manufacturers, and the price is greatly reduced compared to before. ThereforeThe cost of medical examinations is gradually decreasing relative to before, and the people will see less on the medical treatment costs.
Li Yan, deputy director of the Medical Work Institute of Shenzhen Advanced Technology Research Institute of the Chinese Academy of Sciences, introduced that the rapid imaging technology owned by the new instrument avoids the vagueness of the nuclear magnetic resonance imaging.Movement process.
It is reported that the nuclear magnetic resonance instrument is called "pearl on the crown of cutting -edge medical equipment", which has great significance for diagnosis of major diseases such as cardiovascular and cerebrovascular, nerves, and tumors.However, this technology has long been blocked by foreign countries and has been subject to high costs. The per capita per capita ownership of the MRT equipment of China's millions of people's population is less than one -fifth of the United States and Japan.
Report also said that in addition to major breakthroughs in the diagnostic equipment of MRI, Shenzhen Advanced Technology Research Institute of the Chinese Academy of Sciences has also developed non -invasive ultrasonic elasticity that can provide early screening for liver and breast diseases.Imaging technology.In addition, major instruments for the treatment of Parkinson, epilepsy, and Alzheimer's disease have also begun to conduct clinical trials.
According to data from the China State Drug Administration, as of January 2023, there have been more than 32,000 medical device manufacturers in China; in 2022, the operating income of the Chinese medical device industry is about 130 million yuan (RMB, about S $ 24 million), the annual growth rate is about 12%, and the market share is close to one -third of the global market.
